[1]
Jeyalalitha, R. 2017. Empagliflozin and metformin combination therapy in Type 2 diabetes mellitus. International Journal of Basic & Clinical Pharmacology. 4, 6 (Jan. 2017), 1323–1327. DOI:https://doi.org/10.18203/2319-2003.ijbcp20151382.